Kathleen Carol Zelina, - Speech-Language Pathologist in Anchorage, AK

Kathleen Carol Zelina, is a Speech-language Pathologist based in Anchorage, Alaska. Kathleen Carol Zelina is licensed to practice in Alaska (license number 158122) and her current practice location is 525 Cherry St, Anchorage, Alaska. She can be reached at her office (for appointments etc.) via phone at (907) 742-1460.

NPI number for Kathleen Carol Zelina is 1760001622 and her current mailing address is 3542 Julie Ct, Erie, Pennsylvania. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1760001622.

Contact Information

Kathleen Carol Zelina,
525 Cherry St,
Anchorage, AK 99504-2125
(907) 742-1460
Not Available



Healthcare Provider's Profile

Full NameKathleen Carol Zelina
GenderFemale
SpecialitySpeech-language Pathologist
Location525 Cherry St, Anchorage, Alaska
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1760001622
  • Provider Enumeration Date: 04/10/2020
  • Last Update Date: 04/10/2020

Medical Identifiers

Medical identifiers for Kathleen Carol Zelina such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1760001622NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 158122 (Alaska)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kathleen Carol Zelina is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Kathleen Carol Zelina,
3542 Julie Ct,
Erie, PA 16506-6008

Ph: (907) 378-1994
Kathleen Carol Zelina,
525 Cherry St,
Anchorage, AK 99504-2125

Ph: (907) 742-1460

News Archive

Takeda receives FDA response regarding NDA for fixed-dose combination of alogliptin and ACTOS

Takeda Pharmaceutical Company Limited ("Takeda") today announced that its wholly owned subsidiary, Takeda Global Research & Development Center, Inc. (U.S.), received on September 2 (U.S. TIME), a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for the fixed-dose combination (FDC) of alogliptin and ACTOS(R) (pioglitazone HCl).

ADIPOQ gene variations linked to colorectal cancer risk, new study reveals

Adiponectin, a collagen-like protein secreted by fat cells, derives from the ADIPOQ gene. Variations in this gene may increase risk for type 2 diabetes, cardiovascular disease, and various cancers. A new study that links specific variations in the ADIPOQ gene to either higher or lower colorectal cancer risk is published in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

New understanding of keratin 17 protein could lead to development of better ways to prevent cancer

New research from the Johns Hopkins Bloomberg School of Public Health suggests that the protein keratin 17 - the presence of which is used in the lab to detect and stage various types of cancers - is not just a biomarker for the disease, but may play a critical role in tumor growth.

More mothers are breast feeding: Report

The latest figures reveal that the number of new mothers who start breastfeeding is rising. A UK-wide survey showed eight out of ten newborns were put to the breast at least once, up from six out of ten in 1990. The proportion of new mothers who start to breastfeed their babies has risen in the past five years from 76% to 81% across the UK.

Read more News

› Verified 3 days ago


Speech-Language Pathologist in Anchorage, AK

Kathryn Cross, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 12350 Industry Way, 202, Anchorage, AK 99515
Phone: 907-301-4588    
Tracey Keaton, SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 6927 Old Seward Hwy Ste 100, Anchorage, AK 99518
Phone: 907-345-0050    
Christal Hays, MS CCC SLP
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 4441 Diplomacy Dr, Anchorage, AK 99508
Phone: 907-729-8800    
Mrs. Lisa J.c. Rayes, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 4048 Laurel St Ste 303, Anchorage, AK 99508
Phone: 907-562-4550    
Lian Liew Tan, SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 4155 Tudor Centre Dr, Suite #103, Anchorage, AK 99508
Phone: 907-854-8624    
Mrs. Yvonne Marie San Juan, M.S., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 4241 B St Ste 301, Anchorage, AK 99503
Phone: 907-727-0935    Fax: 907-276-7529
Speak From The Heart Llc
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 3351 W 84th Ave, Anchorage, AK 99502
Phone: 907-390-0492    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.